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Previous conferences in this series: 
 
Biochemical Engineering 
August 20-25, 1978 
New England College, Henniker, New Hampshire 
Conference Chairs: 
W. R. Vieth, Rutgers University 
A. Constantinides, Rutgers University 
 
Biochemical Engineering II 
July 13-18, 1980 
New England College, Henniker, New Hampshire 
Conference Chair: 
A. Constantinides, Rutgers University 
 
Biochemical Engineering III 
Sept. 19-24, 1982  
Santa Barbara, California 
Conference Chair: 
K. Venkatsubramanian, H.J. Heinz Co. and Rutgers University 
 
Biochemical Engineering IV 
Sept. 30 - Oct. 5,1984 
Galway, Ireland 
Conference Chairs: 
H. Lim , Purdue University 
Patrick Fottrell, University of Galway 
 
Biochemical Engineering V 
July 27-Aug 1,1986 
New England College, Henniker, New Hampshire 
Conference Chair: 
W.A. Weigand, Illinois Institute Of Technology 
 
Biochemical Engineering VI 
October 2-7,1989 
Santa Barbara, California 
Conference Chair: 
Walter E. Goldstein, ESCA Genetic Corp. 
 
Biochemical Engineering VII 
March 3-8, 1991 
Santa Barbara, California 
Conference Chairs: 
H. Pedersen, Rutgers University 
D. DiBiasio, Worcester Polytechnic 
 
Biochemical Engineering VIII 
July 11-16, 1993 
Princeton, New Jersey  
Conference Chairs: 
Subhash Karkare, Amgen 




Previous conferences in this series: 
 
Biochemical Engineering IX 
May 21-26,1995 
Davos, Switzerland  
Conference Chairs: 
J. Bailey, ETH 
D. Zabriskie, SmithKline Beecham 
 
Biochemical Engineering X 
May 18-23,1997 
Kananaskis, Alberta, Canada  
Conference Chairs: 
W-S. Hu, University of Minnesota 
J. Swartz, Genentech 
 
Biochemical Engineering XI 
July 25-30,1999 
Salt Lake City, Utah  
Conference Chairs: 
George Georgiou, University of Texas 
Steven Lee, Merck & Co., Inc. 
 
Biochemical Engineering XII 
June 10-15, 2001 
Rohnert Park, California 
Conference Chairs: 
Doug Clark, University of California-Berkeley 
Jay Keasling, University of California-Berkeley 
David Robinson, Merck 
 
Biochemical Engineering XIII 
July 19-23, 2003 
Boulder, Colorado  
Conference Chairs: 
Eleftherios Terry Papoutsakis, Northwestern University 
Dr Weichang Zhou, Protein Design Labs 
 
Biochemical Engineering XIV 
July 10-14, 2005 
Harrison Hot Springs, B.C., Canada  
Conference Chairs: 
William Bentley, University of Maryland 
Hendrik J. Meerman, Genencor International, Inc. 
Mike Betenbaugh, Johns Hopkins University 
Vijay Yabannavar, Chiron 
 
Biochemical Engineering XV 
July 15-19, 2007 
Quebec City, Quebec, Canada 
Conference Chairs: 
M. Betenbaugh, Johns Hopkins University 
V. Yabannavar, Trubion Pharmaceuticals 
A. Robinson, University of Delaware 
E. Schaefer, BMS 
 
Previous conferences in this series: 
 
Biochemical Engineering XVI 
July 5-9, 2009 
Burlington, Vermont, USA 
Conference Chairs: 
A. Robinson, University of Delaware 
E. Schaefer, BMS 
 
Biochemical Engineering XVII 
June 26-30, 2011 
Seattle, Washington, USA 
Conference Chairs: 
F. Baneyz, University of Washington 
C. Maranas, Penn State University 
B. Junker, Merck Research 
 
Biochemical Engineering XVIII 
June 16-20, 2013 
Beijing, China 
Conference Chairs: 
David Robinson, Merck 
Tianwei Tan, Beijing University of Chemical Technology 
Huimin Zhao, University of Illinois at Urbana-Champaign 
 
Biochemical Engineering XIX 
July 12-16, 2015 
Puerto Vallarta, Mexico 
Conference Chairs: 
Theresa Good, National Science Foundation 
Gargi Seth, Intas Pharmaceuticals Ltd. 
 
  





The Amgen Award (supported by Amgen, Inc., Thousand Oaks, CA, a leading biotechnology 
company with pioneering human therapeutic products) is given in memory of James E. Bailey to 
recognize research excellence and leadership in Biochemical and Molecular Engineering. An 
award of $5000 cash and a commemorative plaque from Amgen will be presented at the ECI 
Conference on Biochemical and Molecular Engineering in Newport Beach, California.   
The 2017 awardee is Jay Keasling. 
Jay Keasling is the Hubbard Howe Jr. Distinguished Professor of Biochemical Engineering at the 
University of California, Berkeley, in the Departments of Bioengineering and Chemical and 
Biomolecular Engineering, a senior faculty scientist and Associate Laboratory Director for 
Biosciences at Lawrence Berkeley National Laboratory, and Chief Executive Officer of the Joint 
BioEnergy Institute (JBEI).  
Dr. Keasling’s research focuses on the metabolic engineering of microorganisms for degradation 
of environmental contaminants or for environmentally friendly synthesis of drugs, chemicals, and 
fuels. Keasling received a B.S. in Chemistry and Biology from the University of Nebraska and M.S. 
and Ph.D. in Chemical Engineering from the University of Michigan, and did post-doctoral research 
in biochemistry at Stanford University.  
He is a member of the National Academy of Engineering and the National Academy of Inventors. 
Keasling has won numerous awards, including:  
 the 2015 Eric and Sheila Samson Prime Minister’s Prize in Innovation in Alternative Fuels 
for Transportation;  
 the Innovator Award – Biosciences from the Economist Magazine in 2014;  
 the Eni Renewable Energy Prize from Eni S.p.A. in 2014;  
 the George Washington Carver Award for Innovation in Industrial Biotechnology from the 
Biotechnology Industry Organization in 2013;  
 the Promega Biotechnology Research Award from the American Society for Microbiology 
in 2013;  
 the Heinz Award for Technology, the Economy and Employment from the Heinz Family 
Foundation in 2012;  
 International Metabolic Engineering Award from the Metabolic Engineering Society in 
2012;  
 Presidential Green Chemistry Challenge Award from the United States Environmental 
Protection Agency in 2010;  
 the Inaugural Biotech Humanitarian Award from the Biotechnology Industry Organization 
(BIO) in 2009;  
 Scientist of the Year from Discover Magazine in 2006; and  
 the Technology Pioneer Award from the World Economic Forum in 2005.  
 
Keasling is the founder of Amyris, LS9, Lygos, Constructive Biology, and Demetrix. 
2017 Biochemical Engineering Journal Young Investigator Award Winner:  
Radhakrishnan Mahadevan 
 
Launched in 2009, this now annual award recognizes outstanding excellence in research and practice 
contributed to the field of biochemical engineering by a young community member.  The award winner 
receives a cash prize of US $2,500 and presents a Keynote Lecture at the Biochemical and Molecular 
Engineering conference (odd years) or the European Symposium on Biochemical Engineering Sciences 
(even years).   
Radhakrishnan Mahadevan is a Professor in the Department of Chemical Engineering and Applied 
Chemistry and the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. 
He obtained his B.Tech from the Indian Institute of Technology, Madras, in Chemical Engineering in 
1997, and then obtained his PhD. Degree from the University of Delaware in Chemical Engineering in 
2002.  He was a research scientist at Genomatica Inc., San Diego from 2002-2006 and has also held 
appointments as a visiting scholar and a guest lecturer at the Department of Bioengineering at the 
University of California, San Diego, and in the Department of Microbiology, University of Massachusetts, 
Amherst. 
His research interests are in the area of modeling, analysis and optimization of metabolism for 
applications in bioremediations, biochemicals production and medicine. 
He has received the David W. Smith Jr. Best Paper Award in 2006, the Jay Bailey Young Investigator 
Award in Metabolic Engineering in 2010, the Society of Industrial Microbiology and Biotechnology’s 
Young Investigator Award in 2012, the University of Toronto FASE Research Leaders Award in 2013, the 
Alexander von Humboldt Fellowship in 2014, and the Syncrude Innovation Award in 2014.  
His award lecture, scheduled for July 18, 2017 at 11:00 am, is entitled Design principles for control of 










KBI Biopharma Inc. 
National Science Foundation 
UCB Pharma S.A. 
Visit Newport Beach 
  
Notes and room locations 
 Technical sessions will be in the Bay Laurel Central and South rooms.  
 Poster Sessions will be in the Sequoia Ballroom and Bay Laurel North rooms. 
 Workshop locations are listed in the program. 
 Breakfasts and lunches will be in the Bamboo Garden. 
 Dinner on Sunday will be in the Bamboo Garden. 
 Dinners on Monday and Wednesday will be in the Orchid Terrace. 
 The ECI office will be in the Catalina Boardroom. 
 Audiotaping, videotaping and photography of presentations are prohibited. 
 Speakers – Please have your presentation loaded onto the conference computer prior to the 
session start (preferably the day before). 
 Speakers – Please leave at least 3-5 minutes for questions and discussion.  
 Please do not smoke at any conference functions. 
 Turn your mobile telephones to vibrate or off during technical sessions. 
 Please write your name on your program so that it can be returned to you if lost or misplaced. 
 After the conference, ECI will send an updated participant list to all participants. Please check 
your listing now and if it needs updating, you may correct it at any time by logging into your ECI 
account. 
   
Sunday, July 16, 2017 
 
13:00 – 15:30  Conference check-in (Bay Laurel Foyer)   
 
15:30 – 15:50  Welcome from Conference Chairs and ECI Liaison 
   Wilfred Chen, University of Delaware, USA 
Nicole Borth, Universität für Bodenkultur, Vienna, Austria 
Stefanos Grammatikos, UCB Pharma, Belgium 
Beth Junker, ECI Conferences Committee Liaison 
 
15:50 – 19:00  Protein Design, Expression, Processing and Formulation 
Session Chairs: Anne Robinson, Tulane University, USA 
Chris Oostenbrink, University of Natural Resources and Life 
Sciences, Vienna, Austria 
William Bentley, University of Maryland, USA 
 
15:50 – 15:55  Introduction 
 
15:55 – 16:25 Engineered ligand and receptor based fusion proteins as next generation 
cancer therapeutics (Invited) 
 Jennifer Cochran, Stanford University, USA 
 
16:25 – 16:45 Nature inspired antibody design and optimization 
 Peter Tessier, Rensselaer Polytechnic Institute, USA 
 
16:45 – 17:05 Application of phage display and plasmid display to broaden the specificity 
of human Fbs1 for capture of N-glycosylated peptides 
 James C Samuelson, New England Biolabs, USA 
 
17:05 – 17:15 Computational redesign of acyl-ACP thioesterase with improved selectivity 
towards medium chain fatty acids at high production levels 
 Costas Maranas, The Pennsylvania State University, USA 
 
17:15 – 17:45 Coffee break 
 
17:45 – 18:05 Computational prediction of expression and solubility of recombinant 
biopharmaceuticals 
 Alan Dickson, University of Manchester, United Kingdom 
 
18:05 – 18:20 Engineering high titer heterologous protein secretion in bacteria 
 Danielle Tullman-Ercek, Northwestern University, USA 
 
18:20 – 18:35 Intended insoluble expression of recombinant protein with a pull-down tag 
in E. coli for simplifying product purification and increasing yield 
 Daniel Hoffmann, University of Applied Sciences Mittelhessen, Germany 
 
18:35 – 19:00 Establishing cell-free synthetic biology for the production of therapeutic 
glycoproteins and chemicals 
 Mike Jewett, Northwestern University, USA 
 
19:00 – 20:00 Keynote Presentation 
DNA damage, neurodegeneration and mitochondrial dysfunction 
 Vilhelm A. Bohr, National Institutes of Health (NIH), USA 
 
20:00 – 21:30 Dinner 
Monday, July 17, 2017 
 
06:00 – 08:00 Breakfast 
 
08:00 – 10:05 Vaccine Design: From Prevention to Therapeutic Approaches 
 Session Chairs: Paula Alves, IBET & ITQB NOVA, Portugal 
Ravi Kane, Georgia Institute of Technology, USA 
 
08:00 – 08:05 Introduction 
 
08:05 – 08:45 Respiratory Syncytial Virus (RSV)-Vaccines: Engineering immunogenicity 
(Invited) 
 Marty Moore, Emory University, USA 
 
08:45 – 09:05 Bioprocess engineering of insect cells for accelerating vaccines 
development 
 Paula Alves, iBET & ITQB-NOVA, Portugal 
 
09:05 – 09:25 AAV gene therapy for alcoholism: Inhibition of mitochondrial aldehyde 
dehydrogenase enzyme expression in hepatoma cells 
 Anamaria Sanchez, University of Chile, Chile 
 
09:25 – 09:45 Novel approaches to prevent and treat pertussis 
 Jennifer Maynard, University of Texas at Austin, USA 
 
09:45 – 09:50 Engineering the adenylate cyclase toxin for use as a Bordetella pertussis 
vaccine antigen (Poster Spotlights: 5 minutes – 3 slides no questions) 
 Andrea M. DiVenere, University of Texas at Austin, USA 
 
09:50 – 09:55 Toward the identification of cellular mechanisms behind the lethal 
phenotypes in malaria parasites blood stages with PlasmoGEM and 
metabolic modeling (Poster Spotlights: 5 minutes – 3 slides no questions) 
 Anush Chiappino-Pepe, Swiss Federal Institute of Technology (EPFL), 
Switzerland 
 
09:55 – 10:00 Next generation antibody and TCR therapeutics for infectious disease 
(Poster Spotlights: 5 minutes – 3 slides no questions) 
 Ellen K. Wagner, The University of Texas at Austin, USA 
 
10:00 – 10:05 Overcoming challenges in the production of Hepatitis C virus like particles 
(Poster Spotlights: 5 minutes – 3 slides no questions) 
 Manuel Carrondo, IBET & ITQB NOVA, Portugal 
 
10:05 – 10:35 Coffee break 
 
10:35 – 12:55  Visions for Biochemical and Molecular Engineering 
Session Chairs: George Georgiou, University of Texas, USA 
E. Terry Papoutsakis, University of Delaware, USA 
 
10:35 – 10:40  Introduction 
 
10:40 – 11:15 From physics to synthetic biology & entrepreneurship 
 Noah Helman, Industrial Microbes, Emeryville, USA  
 
11:15 – 11:40 Viral vectorology for gene therapy 
 Paula Alves, IBET & ITQB NOVA, Portugal 
 
 
Monday, July 17, 2017 (continued) 
 
11:40 – 12:05 Opportunities and challenges in therapeutics discovery and development 
 George Georgiou, University of Texas, USA 
 
12:05 – 12:30 Opportunities for collective advancement in the biopharmaceutical 
manufacturing community 
 Kelvin H Lee, University of Delaware, USA 
 
12:30 – 12:55 The European biochemical engineer: Extinct? Endangered? Mutated?  
 Stefanos Grammatikos, UCB Pharma, Belgium 
 
12:55 – 14:00 Lunch 
 
14:00 – 16:55  Advances in Bioprocessing 
Sponsored by UCB Pharma S.A. 
Session Chairs: Thomas Ryll, Immunogen, USA 
Martin Gawlitzek, Genentech, Inc., USA 
 
14:00 – 14:05  Introduction 
 
14:05 – 14:35 Exosome-based Biotherapeutics: Opportunities, development and path to 
commercialization (Invited) 
 Konstantin Konstantinov, Codiak BioSciences, USA 
 
14:35 – 14:55 A continuous loop of bioreactors to provide for life support in space 
 Francesc Godia, Universitat Autonoma de Barcelona, Spain 
 
14:55 – 15:15 Acoustic cell concentration, washing & perfusion for cellular therapy 
manufacturing 
   James Piret, University of British Columbia, Canada 
 
15:15 – 15:35 A disruptive alternative to semi-continuous multi-column chromatography 
processes 
 Michael Rose, UCB, United Kingdom 
 
15:35 – 16:05 Coffee break 
 
16:05 – 16:25 Sensitive cells: Enabling tools for static and dynamic control of microbial 
pathways 
 Mattheos Koffas, Rensselaer Polytechnic Institute, USA 
 
16:25 – 16:45 Advancing downstream purification of cell and gene therapy medicinal 
products  
Manuel Carrondo, iBET, Portugal 
 
16:45 – 16:50 Glucocorticoids modulate CHO cell glycosylation in chemically-defined 
media (Poster Spotlights: 5 minutes – 3 slides no questions) 
 Brian Kwan, Merck & Co., Inc., USA 
 
16:50 – 16:55 Process intensification for production of a peste des petites ruminants 
virus (PPRV) vaccine (Poster Spotlights: 5 minutes – 3 slides no questions) 






Monday, July 17, 2017 (continued) 
 
17:00 – 19:10 Genome Engineering 
 Session Chairs: Mike Betenbaugh, Johns Hopkins University, USA 
Sang Yup Lee, KAIST, Korea 
 
17:00 – 17:05 Introduction 
 
17:05 – 17:35 Development of CRISPR-derived technologies for genome regulation and 
applications 
 Stanley Qi, Stanford University, USA 
 
17:35 – 18:00 Rational sRNA design for strain engineering 
 Lydia Contreras, University of Texas-Austin, USA 
 
18:00 – 18:25 Elimination of the “essential” Warburg effect in mammalian cells through a 
multiplex genome engineering strategy 
 Nathan Lewis, University of California, San Diego, USA 
 
18:25 – 18:30 Host cell protein control via CHO genome engineering (Poster Spotlights: 5 
minutes – 3 slides no questions) 
 Jong Youn Baik, University of Delaware, USA 
 
18:30 – 18:35 Generation of a Chinese Hamster Ovary cell genome-wide deletion library 
(Poster Spotlights: 5 minutes – 3 slides no questions) 
 Valerie Schmieder, Austrian Center of Industrial Biotechnology, Austria 
 
18:35 – 18:40 WITHDRAWN 
 
18:45 – 19:10 Genome engineering technologies for programming and recoding 
organisms (Invited) 
 Farren Isaacs, Yale University, USA 
 
19:15 – 20:30 Dinner 
 
20:30 – 22:30 Poster Session 1 
 
 Session Chairs: Astrid Duerauer, Universität für Bodenkultur, Vienna, Austria 
Xiaoxia "Nina" Lin, University of Michigan, USA 



















Tuesday, July 18, 2017 
 
06:00 – 08:00  Breakfast 
 
08:00 – 10:35  Challenges of Miniaturization and Automation in Bioprocess Development\ 
Session Chairs: Alan Dickson, University of Manchester, UK 
Laetitia Malphettes, UCB Pharma, Belgium 
 
08:00 – 08:05  Introduction 
 
08:05 – 08:35 From concept to implementation: How automation enables efficiency gains 
in cell culture process development (Invited) 
   Sven Markert, Roche Diagnostics GmbH, Germany 
 
08:35 – 08:55 Alternative strategy enables automation of up- and downstream processes 
for recombinant production of an antimicrobial peptide in E. coli 
 Mathias Joachim, University of Applied Sciences Mittelhessen, Germany 
 
08:55 – 09:15 High-throughput and miniaturized resin reuse studies 
 Razwan Hanif, UCB, United Kingdom 
 
09:15 – 09:35 High throughput upstream ranging study using AMBR® 250 mini 
bioreactors with DOE and multivariate data analysis (MVDA) 
 Balrina Gupta, Merck & Co., USA 
 
09:35 – 09:50 Facing the challenges – A miniaturized platform for integrated process 
development of products from microbial hosts 
 Astrid Dürauer, University of Natural Resources and Life Sciences Vienna, 
Austria 
 
09:50 – 10:05 Use of AMBR250 as a small scale model for manufacturing-scale single-use 
bioreactors  
 Diana Ritz, GlaxoSmithKline, USA 
 
10:05 – 10:20 Managing transfer and scale-up of a process with atypical impact of 
dissolved oxygen concentration on productivity and product quality  
 Gayle E. Derfus, Gilead Sciences, USA 
 
10:20 – 10:35 An ultra-scale-down method to predict diafiltration performance during 
formulation of concentrated mAb solutions  
 Lara Fernandez-Cerezo, University College London, United Kingdom 
 
10:35 – 11:05 Coffee break 
 
11:05 – 12:05 The Biochemical Engineering Journal Young Investigator Award & Lecture 
 
Award Presentation – Wilfred Chen, University of Delaware 
 
Award Lecture 
Design principles for control of metabolism: Role of enzymatic regulation, 
redundancy and orthogonality 
 Krishna Mahadevan, University of Toronto, Canada 
 
12:05 – 15:00 Lunch and Poster Session 2 
 
 Session Chairs: Astrid Duerauer,  Universität für Bodenkultur, Vienna, Austria 
Xiaoxia "Nina" Lin, University of Michigan, USA 
Javier Femenia, Biomarin Pharmaceutical, USA 
Tuesday, July 18, 2017 (continued) 
 
15:00 – 17:20 Synthetic Biology and Network Design 
 Session Chairs: Kristala Prather, Massachusetts Institute of Technology, USA 
Matias Zurbriggen, University of Düsseldorf, Germany 
 
15:00 – 15:05 Introduction 
 
15:05 – 15:35 Engineering cyanobacteria for use as photosynthetic chemical factories 
(Invited) 
 Brian Pfleger, University of Wisconsin-Madison, USA  
 
15:35 – 15:55 Design of bioswitches for synthetic biology 
 An-Ping Zeng, Hamburg University of Technology, Germany 
 
15:55 – 16:15 Synthetic biology platforms for natural product biosynthesis and discovery  
 James Payne (Christina Smolke Lab), Stanford University, USA  
 
16:15 – 16:35 Post-translational strategies for enhancing biosynthetic pathway 
expression and activity 
 Ian Wheeldon, University of California Riverside, USA 
 
16:35 – 16:55 Engineering xylose metabolism in Thraustochytrid T18 
 Alexandra Merkx-Jacques, Mara Renewables Corporation, Canada 
 
16:55 – 17:15 Filling the knowledge gap in metabolism for analyzing biochemical 
reactions and designing synthetic pathways 
 Vassily Hatzimanikatis, Swiss Federal Institute of Technology (EPFL), 
Switzerland 
 
17:15 – 17:20 A CRISPR/Cas9 based engineering tool to activate expression of multiple 
genes individually or in any specific combination (Poster Spotlights: 5 
minutes – 3 slides no questions) 
 Peter Eisenhut, Austrian Centre of Industrial Biotechnology, Austria 
 
17:20   Free Time and Dinner on your own 
  
Wednesday, July 19, 2017 
 
06:00 – 08:00  Breakfast 
 
08:00 – 10:00  Bionanotechnology 
Session Chairs: Szu-Wen Wang, University of California, Irvine, USA 
Sierin Lim, Nanyang Technological University, Singapore 
 
08:00 – 08:05  Introduction 
 
08:05 – 08:45  Introducing new functions into (and onto) virus-like particles (Invited) 
M.G. Finn, Georgia Institute of Technology, USA 
 
08:45 – 09:10 Human-cell microparticles for cell-therapy and cargo delivery to stem cells  
 Terry Papoutsakis, University of Delaware, USA 
 
09:10 – 09:35 Design of nanoscale therapeutics and nanostructured materials 
 Ravi Kane, Georgia Institute of Technology, USA 
 
09:35 – 10:00 Supramolecular bioenzyme ensemble: Widening of antioxidant protective 
potential 
 Alexander V. Maksimenko, Russian Cardiology Research and Production 
Complex, Moscow, Russia 
 
10:00 – 10:30 Coffee break 
 
10:30 – 10:55 Electrogenetic actuation of gene expression in bacteria: Towards 
programmable biological function based on molecular signaling 
William Bentley, University of Maryland, USA 
 
10:55 – 11:20  Protein nanocage: A versatile molecular carrier 
   Sierin Lim, Nanyang Technological University, Singapore 
 
11:20 – 12:20  Keynote Presentation 
Engineering human physiology:  Discovery and preclinical/clinical 
development of therapeutic proteins in an academic setting 
   George Georgiou, University of Texas at Austin, USA 
 
12:30 – 14:00  Lunch 
 
14:00 – 16:35 Biorenewables and Biofuels 
Session Chairs: Ramon Gonzalez, Rice University, USA 
Vassily Hatzimanikatis, École Polytechnique Fédérale De 
Lausanne (EPFL), Switzerland 
 
14:00 – 14:05  Introduction 
 
14:05 – 14:35 Metabolic engineering of yeast for the synthesis of fatty acid and 
polyketide-based chemicals 
 Nancy Da Silva, University of California, Irvine, USA 
 
14:35 – 14:55 Production of biochemicals and biofuels with no CO2 production and 
improved product yields 





Wednesday, July 19, 2017 (continued) 
 
14:55 – 15:15 Genes to jeans: A green solution to blue denim 
 John E. Dueber, University of California, Berkeley, USA 
 
15:15 – 15:35 Cyclic triterpenoid production with tailored Saccharomyces cerevisiae 
 Birgitta E. Ebert, RWTH Aachen University, Germany 
 
15:35 – 15:55 Succinic acid production from pulp and paper industry waste - A 
transcriptomic approach 
 Chrysanthi Pateraki, Agricultural University of Athens, Greece 
 
15:55 – 16:15 A synthetic regulon enhances the fitness of yeast on non-native nutrients 
 Nikhil Nair, Tufts University, USA 
 
16:15 – 16:35 Rerouting acetyl-CoA and NADPH to improve lipid and oleochemical 
production in Yarrowia lipolytica 
 Peng Xu, University of Maryland Baltimore County, USA 
 
16:35 – 17:15 Coffee Break 
 
17:15 – 18:45 Parallel Workshops 
 
Workshop 1 – Integrated Continuous Manufacturing (Torrey Pine Room) 
 Chairs: Marcella Yu (Boehringer Ingelheim, USA) and Paul Wu (Bayer, USA) 
 
 Workshop 2 – Complexities and Challenges of Antibody-Drug Conjugates 
Development (Bay Laurel Central Room) 
 Chairs: Robert Herbst and Alex Lazar (Immunogen, USA) 
 
 Workshop 3 – Cell Technologies for Cell Therapies (Bay Laurel South Room) 
 Chairs: Manuel Carrondo (IBET, Portugal) and Jeff Chalmers (Ohio State 
 University)  
 
19:00 Dinner, Poster Awards (sponsored by ECI and Biotechnology Journal) and 
Amgen Award Lecture 
 
Amgen Award Presentation – Nitya Jacob, Amgen 
 
Amgen Award Lecture 
Engineered polyketide synthases: Molecular foundries for commodity 
chemicals, specialty chemicals, and biofuels 
Jay Keasling, Lawrence Berkeley National Laboratory, USA 
  
Thursday, July 20, 2017 
 
06:00 – 07:30 Breakfast 
 
07:30 – 09:40 Practical Applications of Modelling: From Protein Structures to Processes 
 Session Chairs: Nathan E. Lewis, University of California, San Diego, USA 
Elmar Heinzle, Saarland University, Germany 
 
07:30 – 07:35 Introduction 
 
07:35 – 08:05 ABC for GRASPing enzyme kinetics in metabolic models (Invited) 
 Lars Keld Nielsen, Australian Institute for Bioengineering and Nanotechnology 
(AIBN), The University of Queensland, Australia 
 
08:05 – 08:25 Predictive macroscopic models of cell growth, metabolism and monoclonal 
antibody production of fed-batch processes at various scales 
 Bassem Ben Yahia, Saarland University and UCB Pharma S.A., Belgium 
 
08:25 – 08:45 Novel stable isotope methods to identify flux bottlenecks in photosynthetic 
hosts 
 Jamey Young, Vanderbilt University, USA 
 
08:45 – 09:05 Genome-scale mapping models and algorithms for stationary and 
instationary MFA-based metabolic flux elucidation 
   Saratram Gopalakrishnan, The Pennsylvania State University, USA 
 
09:05 – 09:25 Automated, simulation-assisted and feedback-guided biomolecular 
engineering 
   Uwe Jandt, Hamburg University of Technology, Germany 
 
09:25 – 09:30 Risk mitigation and resource savings for biological drug product with 
computational fluid dynamics simulation (Poster Spotlights: 5 minutes – 3 
slides no questions) 
Weixian Shi, Bristol-Myers Squibb, USA 
 
09:30 – 09:35 WITHDRAWN 
 
09:35 – 09:40 Investigating crowded metabolism: A molecular particle approach (Poster 
Spotlights: 5 minutes – 3 slides no questions) 
Daniel Robert Weilandt, Swiss Federal Institute of Technology (EPFL), 
Switzerland   
 
09:40 – 10:00  Coffee Break 
 
10:00 – 12:00  Tissue and Stem Cell Engineering 
Sponsored by Biomarin 
Session Chairs: William Miller, Northwestern University, USA 
Lars Keld Nielsen, Australian Institute for Bioengineering and 
Nanotechnology (AIBN), The University of Queensland, Australia 
10:00 – 10:05  Introduction 
 
10:05 – 10:35 Synthetic pre-metastatic niches for detection and analysis of early 
metastatic cells (Invited) 





Thursday, July 20, 2017 (continued) 
 
10:35 – 10:55 The use of intrinsic magnetization to define and separate glioblastoma 
cancer stem cells 
 Jeff Chalmers, The Ohio State University, USA 
 
10:55 – 11:00 Isolation and characterization of cancer stem cells in esophagus squamous 
cell carcinoma (Poster Spotlights: 5 minutes – 3 slides no questions) 
 Pei-Jung Lu, National Cheng Kung University, Taiwan 
 
11:00 – 11:20 Scalable manufacture of pluripotent stem cell derived therapeutics   
   Nick Timmins, CCRM, Canada 
 
11:20 – 11:40 The differentiation of pluripotent stem cells to hepatic cells – Parallels 
between maturation status and metabolic state 
 Wei-Shou Hu, University of Minnesota, USA 
 
11:40 – 12:00 Using computational fluid dynamics (CFD) to design and characterize 
a microfluidic bioreactor for rapid release of culture-derived platelets  
 William Miller, Northwestern University, USA 
 





1.  Process intensification for production of a Peste des Petites Ruminants Virus 
(PPRV) vaccine 
Manuel Carrondo, IBET & ITQB NOVA, Portugal 
 
2.  Glucocorticoids modulate CHO cell glycosylation in chemically-defined media 
Brian Kwan, Merck & Co., Inc., USA 
 
3.  Fractionation of human red blood cells based on intrinsic magnetization 
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